Serum Vitamin D Levels and Antihistamine Treatment Response in Chronic Spontaneous Urticaria: A Retrospective Cohort Study
Introduction: Chronic spontaneous urticaria (CSU) is often refractory, and some patients do not achieve control with second-generation H1-antihistamines (sgAHs). Vitamin D has immunomodulatory effects relevant to mast cell biology, but its relationship with sgAH treatment response, as distinct from disease presence or severity, is poorly characterized. We investigated the association between serum 25-hydroxyvitamin D [25(OH)D] levels and sgAH response in CSU. Methods: This retrospective cohort study included patients with active CSU who had a 25(OH)D measurement within the 3 months preceding diagnosis or on the day of diagnosis. Patients who received vitamin D therapy within 6 months before diagnosis or during follow-up, and those with hepatic, renal or systemic autoimmune disease or prior glucocorticoid or immunosuppressant use, were excluded. Treatment response was assessed with the Urticaria Control Test (UCT) after at least 4 weeks on a stable regimen. Patients reaching UCT ≥12 on sgAH monotherapy, at the licensed dose or after updosing, were classified as sgAH-responsive; those with UCT <12 after at least 4 weeks at four-fold dosing were classified as sgAH-refractory. Analyses included univariate comparisons, receiver operating characteristic (ROC) analysis and age-and sex-adjusted logistic regression. Results: Of 167 patients, 93 (55.7%) were sgAH-responsive and 74 (44.3%) were sgAH-refractory. Median 25(OH)D was higher in sgAH-responsive patients (25.6 vs 15.3 ng/mL; p<0.001). The area under the ROC curve was 0.769 (95% CI 0.693-0.835), and a cutoff of 21.2 ng/mL yielded 67.7% sensitivity and 79.7% specificity. In an age-and sex-adjusted model, each 1 ng/mL increase in 25(OH)D was associated with 12.4% higher odds of sgAH response (OR 1.124, 95% CI 1.075-1.174; p<0.001), independent of season of measurement. Eosinophil and basophil counts, ESR, CRP, thyroid autoantibodies, TSH, total IgE, ANA positivity and comorbidities did not differ between groups. Conclusion: Lower serum 25(OH)D was independently associated with sgAH refractoriness in CSU. Prospective studies are needed to determine whether this reflects a modifiable contributor to treatment response; if confirmed, vitamin D status could be a practical parameter to consider in patients with inadequate response to antihistamines.
Authors
- Orbay Tutku Seren (ORCID: https://orcid.org/0000-0001-9112-8787)
- Ümit Özmen (ORCID: https://orcid.org/0000-0002-2564-393X)
- Hakan Karataş (ORCID: https://orcid.org/0000-0002-3648-3820)
- Aysu Okumuş (ORCID: https://orcid.org/0000-0001-9662-574X)
- Mehmet Emin Kocabaş (ORCID: https://orcid.org/0000-0003-4488-1252)
- Betül Aksu (ORCID: https://orcid.org/0000-0002-3446-9021)
- Papatya Bayrak Deirmenci
- Mehtap Hafzolu
- Sultan Ozaydn Unal
Publication Details
- Journal
- International Archives of Allergy and Immunology
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1159/iaa/adfag051
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00